310
Views
1
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

Evaluation of Medicine Information Leaflets for Omeprazole, Safety Knowledge, and Perceptions of Taking the Medication in Thailand

ORCID Icon, , , ORCID Icon & ORCID Icon
Pages 883-893 | Received 14 Nov 2022, Accepted 10 Mar 2023, Published online: 27 Mar 2023

References

  • Fuchs J, Hippius M, Schaefer M. A survey of package inserts use by patients; 2005. Available from: https://www.paint-consult.com/fileadmin/editorial/downloads/publikationen/PAINT-Consult_package_inserts_use_patients.pdf. Accessed January 15, 2022.
  • Nualdaisri P, Corlett SA, Krska J. Provision and need for medicine information in Asia and Africa: a scoping review of the literature. Drug Saf. 2021;44(4):421–437. doi:10.1007/s40264-020-01038-8
  • Pongpunna S, Pratipanawatr T, Jarernsiripornkul N. Survey of outpatient’s use and needs of patient medicine information leaflets in Thailand. Int J Clin Pharm. 2019;41(1):141–150. doi:10.1007/s11096-018-0748-z
  • Fuchs J, Hippius M. Inappropriate dosage instructions in package inserts. Patient Educ Couns. 2007;67(1–2):157–168. doi:10.1016/j.pec.2007.03.009
  • Pires C, Vigário M, Cavaco A. Readability of medicinal package leaflets: a systematic review. Rev Saude Publica. 2015;49:4. doi:10.1590/s0034-8910.2015049005559
  • Wongtaweepkij K, Corlett S, Krska J, Pongwecharak J, Jarernsiripornkul N. Patients’ experiences and perspectives of receiving written medicine information about medicines: a qualitative study. Patient Prefer Adherence. 2021;15:569–580. doi:10.2147/PPA.S298563
  • Nualdaisri P, Corlett SA, Krska J. The Effectiveness and value of written medicine information across Asia and Africa: systematic review. Drug Saf. 2021;44(12):1283–1295. doi:10.1007/s40264-021-01114-7
  • The Pharmaceutical Society of Australia. Australian Pharmaceutical Formulary and Handbook. 22nd ed. Canberra: Pharmaceutical Society of Australia; 2012.
  • The Medicines and Healthcare Products Regulatory Agency. Best practice guidance on patient information best practice guidance on patient; 2012. Available from: https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/328405/Best_practice_guidance_on_patient_information_leaflets.pdf. Accessed November 9, 2018.
  • Ahmadi P, Badri S, Zargarzadeh A. An investigation on patient attitudes toward package inserts and their accessibility in Iran. J Res Med Sci. 2018;23(1):100. doi:10.4103/jrms.JRMS_67_18
  • Saleem H, Ghoto MA, Memon N, Dayo A, Suheryani I, Shafique S. Assessment of patient’s awareness towards pharmacotherapy and their sources of drug information in different areas of Hyderabad, Pakistan. Int Res J Biol Sci. 2015;4(8):56–59.
  • Ndwiga JM, Kikuvi G, Omolo JO. Factors influencing knowledge on completion of treatment among tb patients under directly observed treatment strategy, in selected health facilities in embu county, Kenya. Pan Afr Med J. 2016;25:234. doi:10.11604/pamj.2016.25.234.8761
  • Jarernsiripornkul N, Phueanpinit P, Pongwecharak J, Krska J. Experiences of and attitudes towards receiving information about non-steroidal anti-inflammatory drugs: a cross-sectional survey of patients in Thailand. Expert Opin Drug Saf. 2016;15(4):417–426. doi:10.1517/14740338.2016.1139571
  • Pongpunna S, Pratipanawatr T, Wongtaweepkij K, Jarernsiripornkul N. Evaluation of patient’s knowledge of atorvastatin information in patient information leaflets: a pre-post intervention study in Thailand. Patient Prefer Adherence. 2021;15:2377–2387. doi:10.2147/PPA.S334668
  • Garner M, Ning Z, Francis J. A framework for the evaluation of patient information leaflets. Heal Expect. 2012;15(3):283–294. doi:10.1111/j.1369-7625.2011.00665.x
  • Luk A, Aslani P. Tools used to evaluate written medicine and health information: document and user perspectives. Heal Educ Behav. 2011;38(4):389–403. doi:10.1177/1090198110379576
  • Koo MM, Krass I, Aslani P. Evaluation of written medicine information: validation of the consumer information rating form. Ann Pharmacother. 2007;41(6):951–956. doi:10.1345/aph.1K083
  • Krass I, Svarstad BL, Bultman D. Using alternative methodologies for evaluating patient medication leaflets. Patient Educ Couns. 2002;47(1):29–35. doi:10.1016/S0738-3991(01)00171-9
  • Desplenter F, Laekeman G, Demyttenaere K, Simoens S. Medication information for Flemish inpatients with major depression: evaluation and construct validity of the consumer information rating form. J Clin Pharm Ther. 2009;34(6):645–655. doi:10.1111/j.1365-2710.2009.01039.x
  • Wongtaweepkij K, Krska J, Pongwecharak J, Pongpunna S, Jarernsiripornkul N. Development and psychometric validation for evaluating written medicine information in Thailand: the consumer information rating form. BMJ Open. 2021;11(10):e053740. doi:10.1136/bmjopen-2021-053740
  • Wongtaweepkij K, Krska J, Pongpunna S, Pongwecharak J, Jarernsiripornkul N. Thai patients’ drug safety knowledge and perceptions relating to different forms of written medicine information: a comparative study. Patient Prefer Adherence. 2022;16:1141–1152. doi:10.2147/ppa.s361447
  • Kinoshita Y, Ishimura N, Ishihara S. Advantages and disadvantages of long-term proton pump inhibitor use. J Neurogastroenterol Motil. 2018;24(2):182–196. doi:10.5056/jnm18001
  • Khan MA, Howden CW. The role of proton pump inhibitors in the management of upper gastrointestinal disorders. Gastroenterol Hepatol. 2018;14(3):169–175.
  • Abdelazim AH, Ramzy S. Application of different quantitative analytical techniques for estimation of aspirin and omeprazole in pharmaceutical preparation. BMC Chem. 2022;16(1):60. doi:10.1186/s13065-022-00854-6
  • El-Olemy A, Abdelazim AH, Ramzy S, et al. Application of different spectrofluorimetric approaches for quantitative determination of acetylsalicylic acid and omeprazole in recently approved pharmaceutical preparation and human plasma. Spectrochim Acta A Mol Biomol Spectrosc. 2021;262:120116. doi:10.1016/j.saa.2021.120116
  • Hanif IF, Syafhan NF, Hersunaryati Y, Andrajati R. Gastrointestinal side effects of Proton Pump Inhibitors on inpatients at Gatot Soebroto Hospital. J Young Pharm. 2017;9(1):s13–s15. doi:10.5530/jyp.2017.1s.4
  • Jaynes M, Kumar AB. The risks of long-term use of proton pump inhibitors: a critical review. Ther Adv Drug Saf. 2018;10:2042098618809927. doi:10.1177/2042098618809927
  • Lemeshow S, Ogston SA, Hosmer DW, Klar J, Lwanga SK. Adequacy of Sample Size in Health Studies. New York: Wiley for the World Health Organization; 1991.
  • Patterson C, Teale C. Influence of written information on patients’ knowledge of their diagnosis. Age Ageing. 1997;26(1):41–42. doi:10.1093/ageing/26.1.41
  • Jarernsiripornkul N, Phueanpinit P, Pongwecharak J, Krska J. Development and evaluation of user-tested Thai patient information leaflets for non-steroidal anti-inflammatory drugs: effect on patient’s knowledge. PLoS One. 2019;14(1):e0210395. doi:10.1371/journal.pone.0210395
  • Bawazir SA, Abou-Auda HS, Gubara OA, Al-Khamis KI, Al-Yamani MJ. Public attitude toward drug technical package inserts in Saudi Arabia. J Pharm Technol. 2003;19(3):209–218. doi:10.1177/875512250301900302
  • Koo MM, Krass I, Aslani P, Guzmàn WM, Le Duff M. Factors influencing consumer use of written drug information. Ann Pharmacother. 2003;37(2):259–267. doi:10.1177/106002800303700218
  • Dodds LJ, King RW. Factors affecting attitudes to the provision of information with prescribed drugs. Pharm J. 1989;242(suppl):R7–R12.
  • Manafo E, Wong S. Exploring older adults’ health information seeking behaviors. J Nutr Educ Behav. 2012;44(1):85–89. doi:10.1016/j.jneb.2011.05.018
  • Al-Aqeel SA. Evaluation of medication package inserts in Saudi Arabia. Drug Healthc Patient Saf. 2012;4(1):33–38. doi:10.2147/DHPS.S29402
  • Burapadaja S, Tantipathananandh P, Sirithunyalug B. Consumer’s opinions on reading a medicine leaflet. Chiang Mai Univ J. 2004;3(2):155–167.
  • Wongtaweepkij K, Krska J, Pongwecharak J, Jarernsiripornkul N. Experiences and views of medicine information among the general public in Thailand. Patient Prefer Adherence. 2020;14:1073–1082. doi:10.2147/PPA.S257454
  • Maat HP, Lentz L, Raynor DK. How to test mandatory text templates: the European patient information leaflet. PLoS One. 2015;10(10):e0139250. doi:10.1371/journal.pone.0139250
  • Morrow DG, Weiner M, Young J, Steinley D, Deer M, Murray MD. Improving medication knowledge among older adults with heart failure: a patient-centered approach to instruction design. Gerontologist. 2005;45(4):545–552. doi:10.1093/geront/45.4.545
  • Raynor DK. User testing in developing patient medication information in Europe. Res Social Adm Pharm. 2013;9(5):640–645. doi:10.1016/j.sapharm.2013.02.007
  • Yamamoto M, Doi H, Yamamoto K, et al. Adaptation of the European Commission-recommended user testing method to patient medication information leaflets in Japan. Drug Healthc Patient Saf. 2017;9:39–63. doi:10.2147/DHPS.S114985
  • Mansoor L, Dowse R. Written medicines information for South African HIV/AIDS patients: does it enhance understanding of co-trimoxazole therapy? Health Educ Res. 2007;22(1):37–48. doi:10.1093/her/cyl039
  • Dowse R, Barford K, Browne SH. Simple, illustrated medicines information improves ARV knowledge and patient self-efficacy in limited literacy South African HIV patients. AIDS Care. 2014;26(11):1400–1406. doi:10.1038/jid.2014.371